Comments
Loading...
Stime degli utili, EPS e fatturato
Bristol-Myers Squibb segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
ott 30
Stima EPS
$1.660
Stima dei ricavi trimestrali
$11.77B
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$47.70B
Analizza lo storico degli utili di Bristol-Myers Squibb utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
BMY | Bristol-Myers Squibb | $1.80 | $1.66 | — | — | $11.89B | $11.77B | — | — | 10/30/2025 | |
BMY | Bristol-Myers Squibb | $2.07 | $1.15 | $1.46 | 26.96% | $12.20B | $11.39B | $12.30B | 8.03% | 07/31/2025 | |
BMY | Bristol-Myers Squibb | -$4.40 | $1.49 | $1.80 | 20.81% | $11.87B | $10.69B | $11.20B | 4.78% | 04/24/2025 | |
BMY | Bristol-Myers Squibb | $1.70 | $1.47 | $1.67 | 13.61% | $11.48B | $11.56B | $12.34B | 6.76% | 02/06/2025 | |
BMY | Bristol-Myers Squibb | $2.00 | $1.49 | $1.80 | 20.81% | $10.97B | $11.28B | $11.89B | 5.43% | 10/31/2024 | |
BMY | Bristol-Myers Squibb | $1.75 | $1.63 | $2.07 | 26.99% | $11.23B | $11.55B | $12.20B | 5.64% | 07/26/2024 | |
BMY | Bristol-Myers Squibb | $2.05 | -$4.44 | -$4.40 | 0.90% | $11.34B | $11.46B | $11.87B | 3.53% | 04/25/2024 | |
BMY | Bristol-Myers Squibb | $1.82 | $1.53 | $1.70 | 11.11% | $11.41B | $11.19B | $11.48B | 2.55% | 02/02/2024 | |
BMY | Bristol-Myers Squibb | $1.99 | $1.76 | $2.00 | 13.64% | $11.22B | $10.97B | $10.97B | -0.04% | 10/26/2023 | |
BMY | Bristol-Myers Squibb | $1.93 | $1.98 | $1.75 | -11.62% | $11.89B | $11.81B | $11.23B | -4.94% | 07/27/2023 | |
BMY | Bristol-Myers Squibb | $1.96 | $1.97 | $2.05 | 4.06% | $11.65B | $11.49B | $11.34B | -1.33% | 04/27/2023 | |
BMY | Bristol-Myers Squibb | $1.83 | $1.72 | $1.82 | 5.81% | $11.98B | $11.20B | $11.41B | 1.84% | 02/02/2023 | |
BMY | Bristol-Myers Squibb | $2.00 | $1.83 | $1.99 | 8.74% | $11.62B | $11.19B | $11.22B | 0.25% | 10/25/2022 | |
BMY | Bristol-Myers Squibb | $1.93 | $1.82 | $1.93 | 6.04% | $11.70B | $11.45B | $11.89B | 3.82% | 07/27/2022 | |
BMY | Bristol-Myers Squibb | $1.74 | $1.91 | $1.96 | 2.62% | $11.07B | $11.36B | $11.65B | 2.54% | 04/29/2022 | |
BMY | Bristol-Myers Squibb | $1.46 | $1.80 | $1.83 | 1.67% | $11.07B | $12.08B | $11.98B | -0.79% | 02/04/2022 | |
BMY | Bristol-Myers Squibb | $1.63 | $1.92 | $2.00 | 4.17% | $10.54B | $11.58B | $11.62B | 0.38% | 10/27/2021 | |
BMY | Bristol-Myers Squibb | $1.63 | $1.91 | $1.93 | 1.05% | $10.13B | $11.33B | $11.70B | 3.29% | 07/28/2021 | |
BMY | Bristol-Myers Squibb | $1.72 | $1.82 | $1.74 | -4.40% | $10.78B | $11.11B | $11.07B | -0.33% | 04/29/2021 | |
BMY | Bristol-Myers Squibb | $1.22 | $1.41 | $1.46 | 3.55% | $7.95B | $10.73B | $11.07B | 3.15% | 02/04/2021 | |
BMY | Bristol-Myers Squibb | $1.17 | $1.49 | $1.63 | 9.40% | $6.01B | $10.33B | $10.54B | 2.03% | 11/05/2020 |
Bristol-Myers Squibb (BMY) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-07-31 | $1.46 | $1.15 | 27.0 % |
| Q1 | 2025-04-24 | $1.80 | $1.49 | 20.8 % |
| Q4 | 2025-02-06 | $1.67 | $1.47 | 13.6 % |
| Q3 | 2024-10-31 | $1.80 | $1.49 | 20.8 % |
Bristol-Myers Squibb (BMY) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-07-31 | $12.30B | $11.39B | 8.03 % |
| Q1 | 2025-04-24 | $11.20B | $10.69B | 4.78 % |
| Q4 | 2025-02-06 | $12.34B | $11.56B | 6.76 % |
| Q3 | 2024-10-31 | $11.89B | $11.28B | 5.43 % |
FAQ
Quando Bristol-Myers Squibb (NYSE:BMY) riporterà gli utili?
Si prevede che Bristol-Myers Squibb (BMY) fornisca risultati il ottobre 30, 2025. Gli ultimi risultati sono stati pubblicati il luglio 31, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di Bristol-Myers Squibb (NYSE:BMY)?
L'EPS effettivo era $1.46, che superato la stima di $1.15.
Quali sono state le entrate di Bristol-Myers Squibb (NYSE:BMY)?
Le entrate effettive sono state $12.3B, che superato la stima di $11.4B.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.